Revenue: UK£885.6k (down 25% from FY 2024).
Net loss: UK£7.32m (loss widened by 122% from FY 2024).
UK£0.26 loss per share (further deteriorated from UK£0.25 loss in FY 2024).
AIM:FDBK Earnings and Revenue History September 20th 2025
All figures shown in the chart above are for the trailing 12 month (TTM) period
Looking ahead, revenue is expected to decline by 4.5% p.a. on average during the next 2 years, while revenues in the Healthcare Services industry in Europe are expected to grow by 11%.
Performance of the market in the United Kingdom.
The company’s shares are down 15% from a week ago.
We should say that we’ve discovered 4 warning signs for Feedback (3 are a bit unpleasant!) that you should be aware of before investing here.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.